國立虎尾科技大學 |

Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis/ edited by Padma V. Devarajan, Prajakta Dandekar, Anisha A. D'Souza.
其他作者:	Devarajan, Padma V.
面頁冊數:	XVIII, 560 p. 82 illus., 45 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmaceutical technology. -
電子資源:	https://doi.org/10.1007/978-3-030-29168-6
ISBN:	9783030291686

Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis[electronic resource] /edited by Padma V. Devarajan, Prajakta Dandekar, Anisha A. D'Souza. - 1st ed. 2019. - XVIII, 560 p. 82 illus., 45 illus. in color.online resource. - AAPS Advances in the Pharmaceutical Sciences Series,392210-7371 ;. - AAPS Advances in the Pharmaceutical Sciences Series,20.

Part 1-Introduction and overview -- Intracellular Delivery in Cancer and Infectious Diseases -- Intracellular Delivery by Receptor Mediated Endocytosis -- Part 2-Receptor and Receptor Medicated Endocytosis in Cancer -- Receptors Relevant for Cancer Therapeutics -- (chapters 3-8) -- Part 3-Receptors and Receptor Medicated Endocytosis in Infectious Diseases -- Receptors Relevant for Infectious Disease Therapeutics -- (chapters 9-13) -- Part 4-Common Receptors for Receptors and Receptor Mediated Endocytosis in Cancer and Infectious Diseases -- Chapters 14-17) -- Receptors Relevant for Cancer and Infectious Disease Therapeutics -- Part 5-Models for Evaluation of Targeted Delivery in Cancer and infectious Diseases -- In vitro and in vivo Models for Cancer and Infectious Diseases -- In vitro and in vivo Models for Infectious Diseases -- Part 6- Regulatory and Toxicity Issues -- Regulatory and Toxicity Issues in Targeted Delivery.

This book elaborates on various aspects of targeting via intracellular delivery, specifically through the Receptor Mediated Endocytosis (RME) approach, due to the involvement of cellular receptors in various grave diseases. Targeted delivery relies on two basic approaches, passive and active targeting. While passive targeting approaches have shown great promise, the improved selectivity achieved with active targeting approaches has resulted in significantly higher efficacy. Interestingly there are numerous strategies for active targeting, many of which are already highlighted in Targeted Drug Delivery: Concepts and Applications. Nevertheless an exciting and practical strategy for active targeting, which could enable high intracellular delivery, is through exploitation of RME. Cells in the body express receptors to enable various physiological and biochemical processes. Many of these receptors are overexpressed in pathological conditions, or newer receptors expressed due to defective cellular functioning. RME is based on exploitation of such receptors to achieve intracellular delivery. While targeted delivery can have manifold applications, in this book we focus on two major and challenging therapeutic areas; i) Cancer and ii) Infectious Diseases. Targeted Intracellular Drug Delivery by Receptor Medicated Endocytosis discusses the major receptors that are useful for targeted delivery for these afflictions. An overview of pathways of intracellular uptake is presented with emphasis on RME pathways. A major section of this book is dedicated to details regarding their occurrence and location, the recognition domain of the receptor, structure activity relationship of substrate /ligand for selective binding, ligands explored, antagonists for ligand binding and relevance of these aspects for therapy of cancer and infectious diseases. These facets are elucidated with the help of specific examples from academic research and also clinical trials, wherever relevant. In vitro cellular models relied on for assessing receptor mediated cellular targeting and in vivo models depicting clinical efficacy are focused on in a separate section. This section also includes a chapter on cellular assays which was conceived to provide hands on training to young and nouveau researchers in the field of targeted nanomedicine. .

ISBN: 9783030291686

Standard No.: 10.1007/978-3-030-29168-6doiSubjects--Topical Terms:

557391
Pharmaceutical technology.

LC Class. No.: RS380

Dewey Class. No.: 615.19

Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
LDR:04769nam a22004095i 4500 001 1004669
003 DE-He213
005 20200705090955.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030291686 $9 978-3-030-29168-6
024 7 $a 10.1007/978-3-030-29168-6 $2 doi
035 $a 978-3-030-29168-6
050 4 $a RS380
050 4 $a RS190-210
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 615.19 $2 23
245 1 0 $a Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis $h [electronic resource] / $c edited by Padma V. Devarajan, Prajakta Dandekar, Anisha A. D'Souza.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XVIII, 560 p. 82 illus., 45 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a AAPS Advances in the Pharmaceutical Sciences Series, $x 2210-7371 ; $v 39
505 0 $a Part 1-Introduction and overview -- Intracellular Delivery in Cancer and Infectious Diseases -- Intracellular Delivery by Receptor Mediated Endocytosis -- Part 2-Receptor and Receptor Medicated Endocytosis in Cancer -- Receptors Relevant for Cancer Therapeutics -- (chapters 3-8) -- Part 3-Receptors and Receptor Medicated Endocytosis in Infectious Diseases -- Receptors Relevant for Infectious Disease Therapeutics -- (chapters 9-13) -- Part 4-Common Receptors for Receptors and Receptor Mediated Endocytosis in Cancer and Infectious Diseases -- Chapters 14-17) -- Receptors Relevant for Cancer and Infectious Disease Therapeutics -- Part 5-Models for Evaluation of Targeted Delivery in Cancer and infectious Diseases -- In vitro and in vivo Models for Cancer and Infectious Diseases -- In vitro and in vivo Models for Infectious Diseases -- Part 6- Regulatory and Toxicity Issues -- Regulatory and Toxicity Issues in Targeted Delivery.
520 $a This book elaborates on various aspects of targeting via intracellular delivery, specifically through the Receptor Mediated Endocytosis (RME) approach, due to the involvement of cellular receptors in various grave diseases. Targeted delivery relies on two basic approaches, passive and active targeting. While passive targeting approaches have shown great promise, the improved selectivity achieved with active targeting approaches has resulted in significantly higher efficacy. Interestingly there are numerous strategies for active targeting, many of which are already highlighted in Targeted Drug Delivery: Concepts and Applications. Nevertheless an exciting and practical strategy for active targeting, which could enable high intracellular delivery, is through exploitation of RME. Cells in the body express receptors to enable various physiological and biochemical processes. Many of these receptors are overexpressed in pathological conditions, or newer receptors expressed due to defective cellular functioning. RME is based on exploitation of such receptors to achieve intracellular delivery. While targeted delivery can have manifold applications, in this book we focus on two major and challenging therapeutic areas; i) Cancer and ii) Infectious Diseases. Targeted Intracellular Drug Delivery by Receptor Medicated Endocytosis discusses the major receptors that are useful for targeted delivery for these afflictions. An overview of pathways of intracellular uptake is presented with emphasis on RME pathways. A major section of this book is dedicated to details regarding their occurrence and location, the recognition domain of the receptor, structure activity relationship of substrate /ligand for selective binding, ligands explored, antagonists for ligand binding and relevance of these aspects for therapy of cancer and infectious diseases. These facets are elucidated with the help of specific examples from academic research and also clinical trials, wherever relevant. In vitro cellular models relied on for assessing receptor mediated cellular targeting and in vivo models depicting clinical efficacy are focused on in a separate section. This section also includes a chapter on cellular assays which was conceived to provide hands on training to young and nouveau researchers in the field of targeted nanomedicine. .
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Pharmacy. $3 582411
650 0 $a Cancer research. $3 1253664
650 0 $a Infectious diseases. $3 1102043
650 1 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Infectious Diseases. $3 668393
700 1 $a Devarajan, Padma V. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1064872
700 1 $a Dandekar, Prajakta. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 934041
700 1 $a D'Souza, Anisha A. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1298187
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030291679
776 0 8 $i Printed edition: $z 9783030291693
830 0 $a AAPS Advances in the Pharmaceutical Sciences Series, $x 2210-7371 ; $v 20 $3 1255084
856 4 0 $u https://doi.org/10.1007/978-3-030-29168-6
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)